BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27439506)

  • 1. Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug.
    Cipolla D; Wu H; Eastman S; Redelmeier T; Gonda I; Chan HK
    Pharm Res; 2016 Nov; 33(11):2748-62. PubMed ID: 27439506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.
    Cipolla D; Wu H; Gonda I; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):411-22. PubMed ID: 26469306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying the release properties of liposomes toward personalized medicine.
    Cipolla D; Wu H; Gonda I; Eastman S; Redelmeier T; Chan HK
    J Pharm Sci; 2014 Jun; 103(6):1851-62. PubMed ID: 24715635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties.
    Cipolla D; Wu H; Gonda I; Chan HK
    AAPS PharmSciTech; 2014 Oct; 15(5):1218-27. PubMed ID: 24889736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation.
    Khatib I; Khanal D; Ruan J; Cipolla D; Dayton F; Blanchard JD; Chan HK
    Int J Pharm; 2019 Jul; 566():641-651. PubMed ID: 31202900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling the size and shape of liposomal ciprofloxacin nanocrystals by varying the lipid bilayer composition and drug to lipid ratio.
    Li T; Clulow AJ; Nowell CJ; Hawley A; Cipolla D; Rades T; Boyd BJ
    J Colloid Interface Sci; 2019 Nov; 555():361-372. PubMed ID: 31398564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid State Characterization of Ciprofloxacin Liposome Nanocrystals.
    Li T; Mudie S; Cipolla D; Rades T; Boyd BJ
    Mol Pharm; 2019 Jan; 16(1):184-194. PubMed ID: 30495965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale Probing of Liposome Encapsulating Drug Nanocrystal Using Atomic Force Microscopy-Infrared Spectroscopy.
    Khanal D; Khatib I; Ruan J; Cipolla D; Dayton F; Blanchard JD; Chan HK; Chrzanowski W
    Anal Chem; 2020 Jul; 92(14):9922-9931. PubMed ID: 32551576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation and surface functionalization of liposomes containing drug nanocrystals for cell-targeted delivery.
    Xiao Y; Liu Q; Clulow AJ; Li T; Manohar M; Gilbert EP; de Campo L; Hawley A; Boyd BJ
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110362. PubMed ID: 31351271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
    Cheow WS; Hadinoto K
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of liposomes containing nanocrystallised ciprofloxacin to digestive media induces solid-state transformation and altered in vitro drug release.
    Li T; Hawley A; Rades T; Boyd BJ
    J Control Release; 2020 Jul; 323():350-360. PubMed ID: 32335156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
    Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
    Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi- and unilamellar liposomal encapsulation of ciprofloxacin as ways to modify its phototoxicity and photodegradation.
    Zgadzaj A; Giebułtowicz J; Gubernator J; Podbielska M; Sommer S; Zaremba-Czogalla M; Nałęcz-Jawecki G
    Eur J Pharm Sci; 2019 Mar; 129():181-189. PubMed ID: 30639399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic vesicles based on biocompatible diacyl glycerol-arginine surfactants: physicochemical properties, antimicrobial activity, encapsulation efficiency and drug release.
    Tavano L; Pinazo A; Abo-Riya M; Infante MR; Manresa MA; Muzzalupo R; Pérez L
    Colloids Surf B Biointerfaces; 2014 Aug; 120():160-7. PubMed ID: 24907585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freeze-anneal-thaw cycling of unilamellar liposomes: effect on encapsulation efficiency.
    Costa AP; Xu X; Burgess DJ
    Pharm Res; 2014 Jan; 31(1):97-103. PubMed ID: 23881305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release.
    Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J
    Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticulate poly(vinyl alcohol) hydrogel formulations for embedding and controlled release of polyethylenimine (PEI)-based nanoparticles.
    Schulze J; Hendrikx S; Schulz-Siegmund M; Aigner A
    Acta Biomater; 2016 Nov; 45():210-222. PubMed ID: 27592816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonionic surfactant structure on the drug release, formulation and physical properties of ethylcellulose microspheres.
    Thakare M; Israel B; Garner S; Ahmed H; Elder D; Capomacchia A
    Pharm Dev Technol; 2017 May; 22(3):418-425. PubMed ID: 27499352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
    Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.